Cure My Disease

Don't miss your cure!

 Log in / Sign up

A helping hand after birth: can support people boost recovery from opioid use disorder?

NCT ID NCT07787039

Disease control Sponsor: Friends Research Institute, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study tests a program called STORC, which trains a support person chosen by the mother and pairs her with a patient navigator to help her find resources after giving birth. The goal is to increase 'recovery capital'—the personal and social resources that help people with opioid use disorder stay in treatment and recover. The trial enrolls women within six weeks of delivery who are receiving or willing to receive treatment for opioid use disorder, along with a support person they identify. The study will first pilot the program to see if it is feasible and acceptable before a larger trial is planned.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A service model that trains a designated support person and provides a patient navigator (peer recovery specialist) to help postpartum women with opioid use disorder build recovery capital and stay in treatment.
What this could lead to
If successful, this approach could offer a practical, community-based way to help new mothers with opioid use disorder stay in treatment and improve their recovery outcomes.
What could go wrong
This is an early, small pilot study (10 participants) focused on feasibility and acceptability, so it may not show clear benefits or be generalizable to larger populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * must be biological females * must be currently within 6 weeks postpartum * must be able to read, write, and speak English at a 6th-grade level * must be diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder at the PROUD clinic * must identify a support person who also consents to participate. Patient participants must identify prospective support persons in order to complete consent Exclusion Criteria: * pregnancy * planned discharge to a long-term inpatient care facility (e.g., hospice) * hospitalization for a suicide attempt * major mental health disorder that requires treatment before OAT can be considered * stillbirth or neonatal death of the index pregnancy/infant, as determined from the obstetric record.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid-use disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.